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Abstract
Non-enzymatic glycation (NEG) and enzymatic biochemical processes create crosslinks that modify the extracellular matrix
(ECM) and affect the turnover of bone tissue. Because NEG affects turnover and turnover at the local level affects
microarchitecture and formation and removal of microdamage, we hypothesized that NEG in cancellous bone is
heterogeneous and accounts partly for the contribution of microarchitecture and microdamage on bone fragility. Human
trabecular bone cores from 23 donors were subjected to compression tests. Mechanically tested cores as well as an
additional 19 cores were stained with lead-uranyl acetate and imaged to determine microarchitecture and measure
microdamage. Post-yield mechanical properties were measured and damaged trabeculae were extracted from a subset of
specimens and characterized for the morphology of induced microdamage. Tested specimens and extracted trabeculae
were quantified for enzymatic and non-enzymatic crosslink content using a colorimetric assay and Ultra-high Performance
Liquid Chromatography (UPLC). Results show that an increase in enzymatic crosslinks was beneficial for bone where they
were associated with increased toughness and decreased microdamage. Conversely, bone with increased NEG required less
strain to reach failure and were less tough. NEG heterogeneously modified trabecular microarchitecture where high
amounts of NEG crosslinks were found in trabecular rods and with the mechanically deleterious form of microdamage
(linear microcracks). The extent of NEG in tibial cancellous bone was the dominant predictor of bone fragility and was
associated with changes in microarchitecture and microdamage.
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Introduction
Age-related bone fracture is a major health problem that can
result in disability and substantial medical care costs [1]. Low bone
mass or bone mineral density (BMD) is considered the key factor
in determining loss of bone strength and increased fracture risk
[2,3]. However, studies demonstrate that decreased bone mass
alone is not sufficient to cause a fracture [4–6]. Therefore, other
factors such as changes in bone quality [7] may also be key
determinants of fracture risk. Bone quality can be altered by
several features including changes in the extracellular matrix
(ECM) and microarchitecture, which interact under applied
loading to influence microdamage formation that can contribute
to bone’s mechanical properties [7,8].
Bone’s ECM components undergo numerous biochemical
changes with aging. Any changes in these constituents can
detrimentally alter the mechanical behavior of bone and explain
the increased fracture incidence in the aging population [5]. In
particular, type I collagen is susceptible to both enzymatic and
non-enzymatic biochemical changes [9]. Both pathways yield
crosslinks, but they affect bone’s mechanical properties differently.
Enzymatic processes produce pyridinium crosslinks (e.g. pyridino-
line [Pyd], deoxypyridinoline [Dpd]) [10,11], which are necessary
for the maturation and mechanical integrity of collagen. On the
other hand, non-enzymatic glycation creates advanced glycation
end products (AGEs) [9,12,13]. Glycation-induced crosslinks are
inversely related to bone toughness [14] and specific AGEs such as
pentosidine explain up to 23% of the variation in bone fracture
toughness [15]. However, since pentosidine is only a single
component of the total fluorescent AGE content in bone,
pentosidine measurement may not be fully illustrative of the
overall influence of glycation on bone fragility [16,17]. AGE
accumulation has been shown to reduce osteoclastic bone
resorption and lead to reduced turnover [18]. Because turnover
affects formation and removal of microdamage and the local
microarchitecture, AGEs may act through reduced turnover and
influence other measures of bone quality associated with bone
fragility.
To date, two studies have been conducted on the effect of
crosslinks on trabecular microarchitecture [19,20] and only a
single study has explored the effects of non-enzymatic glycation on
microdamage formation [21]. These three components of bone
quality may interact with each other and determine the magnitude
of bone fragility, but their relative influence on each other is
currently unknown. For example, both microarchitecture and
bone matrix composition may interact with applied loading to
influence microdamage formation and determine mechanical
properties, which illustrate bone’s ability to resist fracture [22–24].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35047More importantly, it has been recently shown that the presence
of rod-like trabeculae, characteristic of osteoporotic bone, makes
cancellous bone more susceptible to form harmful microdamage
[25–27]. However, no information is available on the extent of
non-enzymatic glycation and microdamage formation within
single trabeculae. This information can help determine if NEG
in cancellous bone is heterogeneous and explain the matrix-based
mechanism through which cancellous bone transitions into a
fragile and weak structure.
Thus, the goal of this study was to determine whether the
trabecular microarchitecture of cancellous bone is heterogeneously
modified by NEG, and whether AGEs are associated with changes
in microarchitecture and microdamage and predict the fracture
properties of cancellous bone. To pursue this goal, cancellous bone
specimens from adult human tibiae were subjected to compression
tests and then quantified for microarchitecture, microdamage, and
the extent of non-enzymatic glycation. Extracted trabeculae were
characterized for microdamage and quantified for AGEs.
Methods
Specimen Collection
42 cancellous bone cores (7.5 mm diameter, 10.5 mm length)
were obtained from tibial plateaus of male (n=24) and female
(n=18) human donors ranging from age 18 to 97 (average
59.3622.1). None of the donors were diagnosed with osteoarthri-
tis, and they were also certified to be free of bone metabolic
diseases, HIV, and hepatitis B (National Disease Research
Interchange and International Institute for the Advancement of
Medicine). All specimens were stored in 280uC in saline soaked
gauze until use.
Microarchitecture and Microdamage Analysis
Each specimen was scanned using micro-computed tomography
(Scanco Medical AG) at 17.5 micron voxel resolution to obtain the
following parameters: volumetric bone mineral density (BMD),
bone volume fraction (BV/TV), connectivity density (Conn.D),
structure model index (SMI), trabecular number (Tb.N), trabec-
ular thickness (Tb.Th), and trabecular separation (Tb.Sp).
Thresholds used to evaluate specimens were determined empir-
ically based on 2D evaluations of a subset of samples.
Mechanical data was collected for a subset of the bone cores
chosen at random (male n=11, female n=12, age range=18–97,
average 60.1623.1). Uniaxial unconfined compression tests to
post-yield (1.1%) apparent-level strain were performed using
established protocols [28–30]. The mechanical testing was
conducted at 37uC in physiological saline using a Bionix 858
servo-hydraulic testing system (MTS) with TestStar II software. An
extensometer (MTS) was used for strain data collection. Stress-
strain data were used to determine several mechanical parameters
including elastic modulus, yield point (using the 0.2% offset
method), ultimate point (determined as the point of maximum
load), post-yield strain (determined as the difference between
ultimate strain and yield strain), post-yield strain energy, and
toughness [28,29,31].
All bone cores were stained using a recently developed
technique allowing for the non-invasive measurement of micro-
damage through micro-computed tomography. The cores were
cleaned of excess blood, fat, and marrow, and stained in a lead-
uranyl acetate solution containing an equal mixture of 20% lead
acetate in 70% acetone and 8% uranyl acetate in 70% acetone for
2 weeks, followed by a 1 week submersion in 1% ammonium
sulfide in acetone [21,32,33].
After staining, the cores were scanned via micro-computed
tomography with the same parameters used previously. Micro-
damage was characterized in a central 8 mm
3 cubic region. The
ratio of damaged volume to bone volume was calculated to
quantify microdamage [21]. This same ratio was also determined
in the region of minimum BV/TV since that region offers a more
accurate prediction of bone fragility compared to overall BV/TV
[34]. The minimum BV/TV region was obtained by dividing the
8m m
3 cubic region into four equally sized volumes and then
selecting the volume with the smallest BV/TV value [27].
19 individual damaged trabeculae were extracted from a subset
of specimens chosen randomly using a random number generator
function in Microsoft Excel (male n=10, female n=9). These
specimens ranged in age from 18 to 97 (average 53.8625.1). Each
trabecula was imaged via microCT using the above-specified
parameters. The ratio of damaged surface area to damaged bone
volume was calculated to characterize the morphology of micro-
damage where higher values indicate more crack-like micro-
damage and lower values indicate more diffuse-like microdamage
[21,27].
Specimen Preparation for Crosslink Analysis of Bone
Cores and Damaged Trabeculae
Individual trabeculae, analyzed for microdamage, were lyoph-
ilized overnight using a freeze dry system (Labconco). They were
then hydrolyzed in 6N hydrochloric acid for 20 hours at 110uC.
Hydrosylates were centrifuged for 30 minutes at 13000 rpm at
4uC to remove any debris. Centrifuged hydrosylates were stored at
280uC in complete darkness until use. A bone slice (7.5 mm
diameter, 1 mm thickness) obtained from each of the 42 bone
cores, was also hydrolyzed and stored in the same fashion.
Collagen quality and purity obtained through this method of
hydrolysis has been previously confirmed in our laboratory via
sodium dodecyl sulfate-polyacrylamide gel electrophoresis [35].
Also, work done in our laboratory has verified that there is no
difference in non-enzymatic glycation content measured in bone
with and without lead-uranyl acetate stain.
Measurement of Total Fluorescent AGEs
The fluorescence was measured for quinine standards (stock:
10 mg/mL quinine per 0.1 N sulfuric acid) and hydrosylates from
individual trabeculae and bone slices at 360/460 nm excitation/
emission using an Infinite 200 microplate reader (Tecan).
Chloramine-T, 3.15 M perchloric acid, and p-dimethylamino-
benzaldehyde solutions were all made immediately before use.
Chloramine-T was added to hydroxyproline standards (stock:
2000 mg/mL L-hydroxyproline per 0.001 N HCl) and sample
hydrosylates. The resulting solution was then incubated at room
temperature for 20 minutes to oxidize hydroxyproline. To quench
chloramine-T, 3.15 M perchloric acid was added and incubated
for 5 minutes at room temperature. Finally, the p-dimethylami-
nobenzaldehyde solution was added and incubated for 20 minutes
at 60uC. All standards and samples were cooled in darkness for
5 minutes. The absorbance was measured at 570 nm using a
microplate reader. Collagen content was calculated based on the
hydroxyproline quantity measured [36]. Total fluorescent AGEs
were quantified in terms of unit quinine per unit collagen.
Individual trabeculae were quantified for total fluorescent AGEs
only, while bone slices from whole bone cores were quantified for
both total fluorescent AGEs as well as specific collagen crosslinks
as described in the next section.
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The hydrosylate from each bone slice was divided in two parts
and each part was used to measure collagen content or crosslinks
by Ultra-high Performance Liquid Chromatography (UPLC,
Waters). A hydroxyproline kit (BioRad) was used for hydroxypro-
line quantification. A Pyd/Dpd calibrator (Quidel) and pentosi-
dine stock (kindly donated by Dr. Vincent Monnier’s group from
Case Western Reserve University) were used as standards for Pyd,
Dpd, and pentosidine quantification using recently developed
methods [35]. This technique has been validated where the
coefficient of variation for the intra-assay and inter-assay for Pyd,
Dpd, and pentosidine were all #2% [35]. All separations were
performed for standards and each specimen hydrosylate (Figure 1).
Separations for hydroxyproline quantification were completed at
60uC with a flow rate of 0.5 mL/min (detector: 471 nm). For
crosslink quantification, separations were achieved at 40uC with a
flow rate of 0.667 mL/min (Pyd and Dpd at 297/395 nm
excitation/emission, pentosidine at 335/385 nm excitation/emis-
sion). Collagen content was calculated based on the measured
hydroxyproline content [36]. All crosslink quantities were
normalized to the amount of collagen.
Statistical Analysis
Outliers were determined as points beyond two standard
deviations of the mean and were removed from analysis. Non-
parametric statistical tests were used for all measures taken in
whole bone specimens because Kolmogorov-Smirnov normality
tests determined that several data sets were not normally
distributed. Spearman correlations were run between enzymatic
crosslink content (Pyd/Dpd), measures of non-enzymatic glycation
(AGEs and pentosidine), microarchitecture, and microdamage for
all specimens. These measures were also tested for correlation with
mechanical parameters measured in the subset of 23 specimens.
Forward stepwise regression tests were conducted for mechanical
properties in order to determine significantly influential variables.
Since data sets were normally distributed for individual trabeculae,
Pearson correlations were run between SMI and the ratio of
damaged surface area to damaged volume as well as between SMI
and total fluorescent AGE content for each trabecula. The power
to detect correlations was approximately 87%. All statistical tests
were performed using SigmaStat version 2.03 (SPSS).
Results
Pentosidine content and total fluorescent AGEs were positively
correlated (r=0.40, p,0.05) at the level of bone cores. However,
they both showed different magnitudes of association with
microarchitecture, microdamage, and mechanical properties
(Table 1). Highly glycated samples had more trabecular rods than
plates (higher SMI) and also contained more microdamage.
Mechanical measures related to bone’s fracture resistance (yield
strain, ultimate strain, and toughness) deteriorated in samples with
high levels of non-enzymatic glycation (Table 1, Figure 2).
In addition their relationships with the extent of non-enzymatic
glycation, microarchitecture and microdamage were also associ-
ated with each other. We found that with increases in micro-
damage quantity, there was deterioration in microarchitecture on
both the global level and region of minimum BV/TV (Table 2).
Also, although several measures of microarchitecture, namely BV/
TV and Conn.D, had some association with bone’s mechanical
properties (Figure 3), microdamage showed a trend towards
significance with yield and ultimate strain (Table 2).
At the level of individual trabeculae, there were relationships
between microarchitecture (SMI) and microdamage content. An
increase in the amount of crack-like microdamage (high ratio of
damaged surface area to damaged volume) was associated with an
increase in SMI (i.e. increase in the relative proportion of
trabecular rods over plates) (r=0.48, p,0.05). Trabeculae
containing crack-like microdamage were more glycated than
trabeculae containing diffuse-like damage (r=0.49, p,0.05).
Two other major variables, donor age and BMD, were
associated with several properties but did not directly correlate
with mechanical parameters. Pentosidine (r=0.44, p,0.01), but
not total fluorescent AGE content (r=0.20, p=0.27), increased
with age. Also, microdamage content at a global level increased
(r=0.31, p=0.06) increased with age. Age had no significant
relationship with microarchitecture. On the other hand, BMD was
positively correlated with BV/TV (r=0.26, p=0.10) and Tb.Th
(r=0.42, p,0.01). However, BMD had no relationship with
microdamage or non-enzymatic glycation content.
There was no relationship between enzymatic crosslinks and age
or BMD. Pyd/Dpd was negatively associated with pentosidine
(r=20.27, p=0.054), but not with total fluorescent AGEs.
Additionally, increased Pyd/Dpd was associated with increased
bone toughness and decreased microdamage content (Table 1).
Pyd/Dpd was also associated with several microarchitectural
properties (Table 1).
Forward stepwise regression tests to predict yield strain
(p,0.05), ultimate strain (p,0.05), and toughness (p,0.05) as
dependent variables using all significant properties as independent
variables showed that, regardless of the numerous existing
interrelationships, the extent of non-enzymatic glycation (total
fluorescent AGEs or pentosidine) was the only significant
predictive variable of mechanical properties.
Figure 1. Schematic of UPLC chromatogram. Eluted peak areas were used for quantification of Pyd, Dpd, and pentosidine.
doi:10.1371/journal.pone.0035047.g001
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Non-enzymatic glycation has been shown to deteriorate bone’s
mechanical parameters, but its distribution within cancellous bone
and the extent of its influence on fracture in comparison to other
changes in bone quality remains unclear [14,28,37,38]. Our goal
was to determine if microarchitecture of cancellous bone is
heterogeneously modified by NEG, and if AGEs predict the
fracture properties of cancellous bone and correlate with changes
in microarchitecture and microdamage.
In contrast to AGEs, pentosidine is more commonly used as a
marker of NEG in bone [16,28,37]. However, it is not known
whether measurement of pentosidine is adequate to illustrate the
effects of non-enzymatic glycation on the mechanical integrity of
bone [15]. Our results show that pentosidine explained 40% of the
variance in bulk fluorescent AGE content and comprises only a
portion of total fluorescent AGEs. Unlike age-dependence of
pentosidine concentration [15,39], our data indicated that total
fluorescent AGEs in human tibial cancellous bone do not follow
this trend and may therefore, contribute differently to the overall
influence of non-enzymatic glycation. Moreover, unlike pentosi-
dine, our data illustrated that AGE content predicted bone
toughness. Thus, pentosidine alone does not represent the
collective effects of all AGEs on bone fracture.
Figure 2. Mechanical properties versus NEG crosslinks. Graphical data for several mechanical parameters versus total fluorescent AGEs (top)
and pentosidine (bottom) are shown.
doi:10.1371/journal.pone.0035047.g002
Table 1. Relationships between crosslink content and mechanical properties, microarchitecture, and microdamage content.
Total fluorescent AGEs Pentosidine Pyd/Dpd
[ng Quinine/mg collagen] [mmol/mol collagen] [mg/mmol]
Mechanical properties Elastic modulus [N/mm
2] 0.13 (NS) 0.13 (NS) 0.29 (NS)
Yield stress [N/mm2] 0.01 (NS) 20.17 (NS) 0.28 (NS)
Yield strain 0.54 (,0.01) 0.46 (,0.05) 20.45 (NS)
Ultimate stress [N/mm2] 20.03 (NS) 20.21 (NS) 0.32 (NS)
Ultimate strain 0.38 (=0.09) 0.44 (,0.05) 20.36 (NS)
Toughness [mJ/mm
3] 20.39 (=0.08) 20.25 (NS) 0.49 (=0.06)
Microarchitecture BV/TV 0.06 (NS) 20.14 (NS) 0.38 (,0.05)
Conn/D [1/mm
3] 0.21 (NS) 20.02 (NS) 0.43 (,0.05)
SMI 0.54 (,0.01) 0.38 (,0.05) 20.29 (=0.11)
Tb.N [1/mm] 0.29 (NS) 20.11 (NS) 0.57 (,0.01)
Tb.Th [mm] 0.03 (NS) 0.09 (NS) 0.35 (,0.05)
Tb.Sp [mm] 0.27 (NS) 0.22 (NS) 20.56 (,0.01)
Microdamage content Global level 0.26 (NS) 0.35 (=0.054) 20.39 (,0.05)
Region of minimum BV/TV 0.43 (,0.05) 0.55 (,0.01) 20.20 (NS)
Data is presented as the Spearman correlation coefficient with the p-value in parentheses. NS=not significant. Variables showing significance (p,0.05 but ,0.10) are
shown in bold.
doi:10.1371/journal.pone.0035047.t001
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crosslinking on trabecular microarchitecture. Microarchitecture is
known to interact with applied loading at multiple length scales
[20,23] and form in vivo microdamage of distinct morphologies,
which reflect the quality and fracture resistance of bone matrix
[40]. However, one of these two studies was limited to
quantification of enzymatic crosslinks while using 2D histomor-
phometric methods for microarchitectural imaging [19]. The
other more recent work included measurement of non-enzymatic
crosslinks and used 3D microCT imaging methods; however, it
measured only pentosidine [20].
Out of all microarchitectural variables, our study found that
increased glycation showed a strong positive correlation only with
SMI. SMI illustrates the prevalence of rods and plates in a
trabecular network where an increase in SMI illustrates a
transition from plate-like to rod-like trabecular structure. AGEs
may cause an alteration in turnover and, as a result, affect the
microarchitecture. In particular, the inside of trabeculae is
composed of older bone tissue that is sandwiched between
trabecular packets. Working with cortical bone, we have
demonstrated that older bone tissue contains higher AGE levels
including pentosidine in comparison to younger bone tissue [41].
This evidence, combined with previous results showing a negative
relationship between AGEs and in vitro bone resorption by
osteoclasts [18], and between AGEs and bone turnover [37],
strongly suggests that rods would contain more AGEs than plates,
as was found in our study. Therefore, non-enzymatic glycation
may act via the reduced propensity of osteoclastic resorption to
retain fragile trabecular rods in the structural network.
Since the accumulation of AGEs increases bone fragility, the
high glycation level in rod-like trabeculae may further weaken the
cylindrical structures, which are already prone to bending and
buckling [42]. Consistent with this notion, we found that the rod-
like trabeculae are indeed more prone to producing crack-like
microdamage (Figure 4), which may further contribute to the
failure of trabecular rods than plates.
Figure 3. Mechanical properties versus microarchitecture.
Several microarchitectural properties were correlated with cancellous
bone’s mechanical parameters.
doi:10.1371/journal.pone.0035047.g003
Table 2. Relationships between microdamage content, mechanical properties, and microarchitecture.
Microdamage content Microdamage content
Global level Region of minimum BV/TV
Mechanical properties Elastic modulus [N/mm
2] 20.09 (NS) 0.00 (NS)
Yield stress [N/mm2] 20.37 (NS) 20.34 (NS)
Yield strain 0.41 (=0.08) 0.37 (NS)
Ultimate stress [N/mm2] 20.39 (NS) 20.39 (=0.09)
Ultimate strain 0.38 (NS) 0.29 (NS)
Toughness [mJ/mm
3] 20.06 (NS) 0.10 (NS)
Microarchitecture BV/TV 20.37 (,0.05) 20.33 (,0.05)
Conn/D [1/mm
3] 20.34 (,0.05) 20.19 (NS)
SMI 0.30 (=0.08) 0.38 (,0.05)
Tb.N [1/mm] 20.43 (,0.01) 20.31 (=0.07)
Tb.Th [mm] 20.16 (NS) 0.00 (NS)
Tb.Sp [mm] 0.50 (,0.01) 0.42 (,0.05)
Data is presented as the Spearman correlation coefficient with the p-value in parentheses. NS=not significant. Variables showing significance (p,0.05 but ,0.10) are
shown in bold.
doi:10.1371/journal.pone.0035047.t002
Figure 4. NEG influences microdamage morphology. (Left)
Higher NEG levels exist in rod-like trabeculae compared to plate-like
trabeculae. (Right) Also, rod-like trabeculae are prone to producing
more crack-like microdamage.
doi:10.1371/journal.pone.0035047.g004
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glycation affects mechanical properties along with alterations in
microdamage [21], but this study was done in a single donor. To
improve on this previous work, our project explored in vivo
glycation in 42 donors with a wide age and BV/TV range and
investigated the relationship of non-enzymatic glycation with
changes in microdamage and microarchitecture. Similar to
previous findings, we found that rod-like trabeculae in a weakened
microstructure are conducive to increased formation of micro-
damage [21], and that glycation altered the extent of accumulated
microdamage in bone.
AGEs, microarchitecture, and microdamage are therefore all
interrelated to bone’s mechanical properties, and show relation-
ships with yield strain, ultimate strain, and toughness in our study.
Furthermore, measures of non-enzymatic glycation are also
correlated to microarchitectural variables, microdamage content,
and mechanical properties. Due to the host of interrelated factors,
it was necessary to establish the leading variables that influence
mechanical properties. Although microdamage was associated
with microarchitecture, and microarchitecture was directly
correlated with mechanical parameters, our forward stepwise
regression analysis indicated that the extent of glycation was the
only dominant predictor. Unlike previous results on cancellous
bone [2,43], we did not find correlations between microdamage
content and mechanical properties in cancellous bone. These
differences between our and previous studies may indicate that the
effect of bone quality measures including microdamage may be
site specific, and microdamage may have a greater influence on
the fracture of low density vertebral bone. Further work is
necessary to explain such differences.
Measurement of enzymatic crosslinks is critical because they are
also determinants of bone quality [44,45] and may positively affect
bone’s mechanical strength [46]. In particular, the Pyd/Dpd ratio
is illustrative of collagen maturity since both of these crosslinks
provide the fibers with strength and stability [47,48]. A previous
study, in which the relationship between enzymatic crosslinks and
bone strength was investigated, showed that high Pyd/Dpd bone
was stronger than low Pyd/Dpd bone [49]. Here, we found that
high Pyd/Dpd bone was tougher than low Pyd/Dpd bone.
Additionally, high Pyd/Dpd was less glycated, had more favorable
microarchitecture, and contained less microdamage than low
Pyd/Dpd bone. Our results reconfirm that enzymatic crosslinking
in bone is a favorable process.
Our data should be considered in light of a limitation. 1–2 data
points, associated with high amount of pentosidine, leverage the
magnitude of association between pentosidine and mechanical
properties (i.e. yield strain, Figure 2). Because removal of these
points was not statistically justifiable, these points remained in our
final analyses. A previous study on human cancellous bone also
showed several donors with high pentosidine levels (beyond
40 mmol pentosidine per mol collagen) similar to the higher
values seen in our work [50]. However, in order to further clarify
the relationship between non-enzymatic glycation and mechanical
properties, future work should consider inclusion of more samples
with high pentosidine concentrations, associated with advanced
age [39], diabetes [51–52] and anti-resorptive treatments [37].
In conclusion, we found that non-enzymatic glycation hetero-
geneously modified cancellous bone’s trabecular microarchitecture
where high amounts of AGEs were found in trabecular rods and
with linear microcracks. We found that the extent of NEG in
human tibial cancellous bone was the dominant predictor of bone
fragility and was associated with changes in microdamage and
microarchitecture.
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